The assessment of serum levels of prostate specific antigen (PSA), a member of the kallikrein gene family, is still carried out for PCa screening, even though the classification of PSA as a PCa biomarker has become increasingly controversial due to the lack of specificity [36]. This evidence concerns the gene KLK4 and posterior cortical atrophy.